Dr. Sri Harsha Talluri

OP Timing:

Dr. Sri Harsha Talluri is the only surgical oncologist in the twin cities to receive MS and M.Ch. Surgical oncology from the prestigious All India Institute of Medical Sciences New Delhi.

He was the topper in both General Surgery and Surgical Oncology residency programs from the premier institute of medical training in the country. 

He has extensive experience managing advanced ovarian cancer patients with cytoreductive surgery and HIPEC (Hyperthermic Intraperitoneal Chemotherapy), EPIC (Early postoperative Intraperitoneal Chemotherapy), and PIPAC.

He is also trained in minimally invasive oncosurgery in performing advanced laparoscopic procedures like Laparoscopic Abdominoperineal resections, Ultralow/low anterior resections, pelvic exenterations, Laparoscopic colectomy, Laparoscopic Radical Gastrectomy, minimally invasive esophagectomy (Lap + VATS), VATS (Video-assisted thoracoscopic surgery) lung resections.

He has gained experience in oncoplastic breast surgery from stalwarts in the field of breast surgery and offers breast conservation surgery, sentinel lymph node biopsy, reconstructive breast surgery, along with mastectomy in the management of breast cancer patients. He has vast experience managing early and locally advanced head and neck cancers requiring complex resections and thyroid cancers.

He is trained in the multidisciplinary management of soft tissue sarcomas of retroperitoneum and extremity and offers complex limb salvage and organ-sparing procedures.

He also performs open/laparoscopic partial/radical nephrectomy and cystectomy to manage urinary tract malignancies.

I. Qualification / Education:

• MBBS, Osmania Medical College, Hyderabad 2008-2013
• M.S. (General Surgery), All India Institute of Medical Sciences (AIIMS, New Delhi) 2015-2018
• M.Ch. (Surgical Oncology), All India Institute of Medical Sciences (AIIMS, New Delhi) Jan 2020- Dec 2022

II. Experiences:

• Internship in Osmania General Hospital 2013-2014
• Junior Resident surgeon in AIIMS New Delhi 2015-2018
• Senior Resident surgeon in Institute Rotary Cancer Hospital and National Cancer Institute – AIIMS New Delhi 2018-2020
• Senior Resident surgeon (Academic) in Institute Rotary Cancer Hospital and National Cancer Institute – AIIMS New Delhi 2020-2022

III. Honors:

• First rank in M.Ch. Surgical Oncology from prestigious AIIMS New Delhi.
• First rank in M.S. General Surgery from prestigious AIIMS New Delhi.
• Global Surgery program traveling fellowship awarded by Duke NUS and National Cancer Centre Singapore.
• Young Gynaecologic oncologist award for paper on HIPEC in ovarian cancer management presented in Asian society of Gynaecological Oncology conference 2021 - Thailand.
• Best paper award in ASICON 2021 (Annual conference of Association of Surgeons, India)
• Best poster award in ONCOVISION 2022 (5th annual conference of Delhi oncology forum)
• Best poster in NATCON 2021 (Annual conference of Indian Association of Surgical Oncologists).
• Best poster in 77th Annual conference of Association of Surgeons of India for poster on Breast cancer management
• Participated in Breast Cancer Preceptorship sponsored by European Society of Medical Oncology, Singapore, November 2017

IV. Paper Presentations:

• “Quality of care indicators for CRS HIPEC in advanced epithelial ovarian cancer” in the 5th annual conference of the Delhi oncology forum in 2022
• Role of Early Postoperative Intraperitoneal Chemotherapy in management of ovarian Cancer in Low and Middle Income Country in Singhealth Peritoneal Surface Oncology conference in Singapore.
• “Cytoreductive surgery (CRS) after neoadjuvant chemotherapy in ovarian cancer, Does Neoadjuvant chemotherapy really ease the burden?” in Asian society of Gynecological Oncology conference 2021 
• “Perioperative outcomes of peritoneal surface malignancy of ovarian origin following Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS and HIPEC) – Experience from tertiary care center” in ASICON 2021
• “Patterns and predictors of recurrence in advanced epithelial ovarian cancer after CRS and HIPEC” in NATCON 2021
• “Thyroid Isthmusectomy: Experience at A Tertiary Care Centre” in 16th Biennial conference Asian Association of Endocrine Surgeons in March 2018.

V. Poster Presentations:

• “Bilateral breast cancer – Is 1+1=2?”  Armed forces oncology group and Delhi oncology forum 5th annual conference ONCOVISION-2022.
• “Is it better to Peep or to barge in?  Minimally Invasive versus Open esophagectomy in Indian patients” in ONCOVISION 2022 Delhi.
• “Systematic protocol based multidisciplinary approach for optimizing outcomes of cytoreductive surgery and HIPEC – Single institution experience of 246 cases” in IASO- NATCON 2021, India.
• “Geriatric Breast cancer: Does age matter? in ESMO Breast cancer conference 2022 in Berlin, Germany.
• “Role of ultrasonography, Mammography, Clinical examination in predicting pathological complete response to neoadjuvant chemotherapy” in 77th Annual conference of Association of Surgeons of India (ASICON Jaipur).
• “Pelvic Exenteration – Boon or a Bane ?” in European Society of Gynaecological Oncology 2022 Congress in Berlin, Germany.

VI. Publications:

• Ray M, Oberoi AS, Surya T, Saikia J. Management of Lymphatic Leaks After Retroperitoneal Lymph-Node Dissections in Gynecologic Cancers. Journal of Gynecologic Surgery. 2022 Apr;38(2):133–7.
• Bhoriwal S, Sharma J, Dhall K, Mandal A, Chhebbi M, Surya TSHV. Duplication of the internal jugular vein – A rare anatomical variation. Oral Oncology. 2021 Jan 1;112:104985.
• Ray MD, TSHV Surya, Premanand N. Does Interval CRS stand better than Primary CRS in Advanced Carcinoma Ovary: A Comparative Study with Technical Description | Abstract [Internet]. [cited 2022 Oct 8]. Available from: https://www.iomcworld.org/abstract/does-interval-crs-stand-better-than-primary-crs-in-advanced-carcinoma-ovary-arncomparative-study-with-technical-descript-94536.html

• Comparing Hyperthermic Intra Peritoneal Chemotherapy (HIPEC) with Early Postoperative Intraperitoneal Chemotherapy (EPIC) in ovarian cancer management.
• Audit and Analysis of Peritoneal surface malignancy database – IRCH, AIIMS New Delhi.
• Evaluation of The Role of Radical Radiotherapy in Achieving Pathological Complete Response in Breast Cancer Patients with Complete Clinical Response Following Neo Adjuvant Chemotherapy: A Superiority Randomized Controlled Trial.

VIII. Workshops:

• AIIMS- UK (NHS) Cadaver course on Breast Oncoplastic and Reconstruction on 28th and 29th August 2019, JPNATC, AIIMS, New Delhi
• Colorectal cancer - updates on MIS and video workshop at AIIMS, New Delhi, Nov 2019.
• Robotic Onboarding Program and Education (ROPE). By Intuitive. 29th September, 6th October, 13th October, 20th October, 19th November, 2020 and 12th January and 19th January, 2021.
• Peritoneal surface oncology workshop on CRS and HIPEC/ PIPAC conducted by National Cancer Center Singapore

IX. Membership & Affiliation:

• Association of Surgeons of India
• Indian Association of Surgical Oncology 
• European Society of Medical Oncology
• Telangana Medical Council
• Delhi Medical Council